Levofloxacin Aurovitas

Levofloxacin, the active ingredient in Levofloxacin Aurovitas, is a fluoroquinolone antibiotic presented as an oral formulation for systemic use. It treats a range of bacterial infections in adult patients, including respiratory, urinary and skin infections, by targeting bacterial DNA replication mechanisms.

GNH USA supplies Levofloxacin Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable logistics for global distribution in many countries across Europe, Asia and the Americas.

Levofloxacin is a fluoroquinolone antibiotic indicated for several bacterial infections affecting the respiratory, urinary and integumentary systems.

- Community‑acquired pneumonia: eradicates the causative bacteria, leading to clinical improvement and resolution of pulmonary infiltrates. - Acute bacterial sinusitis: reduces sinus inflammation by eliminating the infecting organisms and relieving congestion. - Acute exacerbations of chronic bronchitis: controls bacterial overgrowth, decreasing cough and sputum production. - Uncomplicated urinary tract infections: clears the uropathogen, resulting in symptom relief and prevention of recurrence. - Skin and soft tissue infections: targets common skin pathogens, promoting healing of cellulitis, abscesses and wound infections.

Levofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Insomnia - Rash

Serious or Rare Side Effects: - Tendon rupture or tendinitis - Peripheral neuropathy - QT interval prolongation - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome) - Clostridioides difficile‑associated diarrhea - Hepatic dysfunction or elevated liver enzymes

When prescribing Levofloxacin, clinicians should observe several precautionary measures to minimize risk.

- Assess renal function: adjust dose in patients with impaired clearance. - Evaluate hypersensitivity: avoid in individuals with known fluoroquinolone allergy. - Use caution in elderly: increased susceptibility to tendon injury and CNS effects. - Monitor for tendon pain: discontinue if pain, swelling or inflammation occurs. - Avoid concomitant QT‑prolonging drugs: reduce risk of cardiac arrhythmias. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Levofloxacin interacts with several drug classes; some combinations should be avoided while others require close monitoring.

Major Interactions (Avoid): - Antacids or supplements containing magnesium, aluminum, calcium, or iron: markedly reduce absorption. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of CNS stimulation and seizures. - Cyclosporine: elevated cyclosporine levels may occur, raising nephrotoxicity risk. - Theophylline: plasma concentrations can rise, leading to toxicity.

Moderate Interactions (Monitor Closely): - Oral contraceptives: efficacy may be reduced, consider alternative contraception. - Corticosteroids: combined use may heighten risk of tendon rupture. - Antidiabetic agents (e.g., sulfonylureas): blood glucose may drop, monitor levels. - HIV protease inhibitors: may increase levofloxacin exposure, adjust dose if needed. - Diabetic agents: potential hypoglycemia, require glucose monitoring.